Taro Pharmaceutical Industries Ltd (TARO)
42.41
+0.13
(+0.31%)
USD |
NYSE |
May 09, 15:06
Taro Pharmaceutical Industries Net Income (Quarterly): 20.21M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.21M |
| September 30, 2023 | 8.547M |
| June 30, 2023 | 10.03M |
| March 31, 2023 | 6.913M |
| December 31, 2022 | 7.265M |
| September 30, 2022 | -2.813M |
| June 30, 2022 | 14.08M |
| March 31, 2022 | 27.40M |
| December 31, 2021 | 26.31M |
| September 30, 2021 | 23.32M |
| June 30, 2021 | -18.77M |
| March 31, 2021 | -29.79M |
| December 31, 2020 | 32.92M |
| September 30, 2020 | 45.13M |
| June 30, 2020 | -434.92M |
| March 31, 2020 | 54.20M |
| December 31, 2019 | 67.68M |
| September 30, 2019 | 56.18M |
| June 30, 2019 | 66.18M |
| March 31, 2019 | 58.43M |
| December 31, 2018 | 93.51M |
| September 30, 2018 | 62.56M |
| June 30, 2018 | 67.28M |
| March 31, 2018 | 86.29M |
| December 31, 2017 | 17.97M |
| Date | Value |
|---|---|
| September 30, 2017 | 52.39M |
| June 30, 2017 | 54.50M |
| March 31, 2017 | 82.99M |
| December 31, 2016 | 139.82M |
| September 30, 2016 | 123.66M |
| June 30, 2016 | 109.90M |
| March 31, 2016 | 114.95M |
| December 31, 2015 | 189.00M |
| September 30, 2015 | 133.35M |
| June 30, 2015 | 103.64M |
| March 31, 2015 | 152.29M |
| December 31, 2014 | 142.48M |
| September 30, 2014 | 143.38M |
| June 30, 2014 | 46.10M |
| March 31, 2014 | 89.64M |
| December 31, 2013 | 115.62M |
| September 30, 2013 | 96.34M |
| June 30, 2013 | 58.80M |
| March 31, 2013 | 49.17M |
| December 31, 2012 | 88.78M |
| September 30, 2012 | 65.35M |
| June 30, 2012 | 62.91M |
| March 31, 2012 | 47.25M |
| December 31, 2011 | 62.40M |
| September 30, 2011 | 58.94M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-434.92M
Minimum
Jun 2020
67.68M
Maximum
Dec 2019
-1.048M
Average
20.21M
Median
Dec 2023
Net Income (Quarterly) Benchmarks
| InspireMD Inc | -5.405M |
| BiomX Inc | -5.491M |
| Alpha Tau Medical Ltd | -7.365M |
| Pluri Inc | -4.905M |
| Holdco Nuvo Group DG Ltd | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 157.14M |
| Total Expenses (Quarterly) | 141.26M |
| EPS Diluted (Quarterly) | 0.54 |
| Enterprise Value | 686.86M |
| Gross Profit Margin (Quarterly) | 50.83% |
| Profit Margin (Quarterly) | 12.86% |
| Earnings Yield | 2.88% |
| Operating Earnings Yield | 1.38% |
| Normalized Earnings Yield | 2.872 |